Inventor · disambiguated record
Mark Bazett
Also filed as: BAZETT MARK
2 granted patents·3 pending applications·1 citations·filing 2017–2022
32Inventor score
Top patents by PatentIndex Score
5 records- 0166US11226340B2Therapeutically triggering an innate immune response in a target tissueQU BIOLOGIES INC·Filed 2017·Granted Jan 18, 2022·1 cites·14 claims
- 0252US2022236284A1Therapeutically Triggering an Innate Immune Response in a Target TissueQU BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 0350US2024115582A1Use of sodium trans-[tetrachloridobis(1h-indazole)ruthenate(iii)] for treating cancersBOLD THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0446US2025235465A1Use of sodium trans-[tetrachloridobis(1h-indazole)ruthenate(iii)] to ameliorate proteasome inhibitor resistanceBOLD THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0543US12491153B2Innate targeting of adoptive cellular therapiesQU BIOLOGICS INC·Filed 2018·Granted Dec 9, 2025·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →